Логачева Ирина Вячеславовна (RU),Рязанова Татьяна Александровна (RU),Пономарёв Сергей Борисович (RU),Макарова Виктория Равильевна (RU)
申请号：
RU2018127134
公开号：
RU2018127134A
申请日:
2018.07.23
申请国别(地区):
RU
年份:
2020
代理人:
摘要：
FIELD: medicine.SUBSTANCE: invention refers to medicine, namely to gastroenterology, and can be used for prediction of development of non-alcoholic fatty liver disease. Body weight index, epicardial adipose tissue thickness, intra-abdominal fat thickness are measured, thickness of the posterior wall of the left ventricle of heart and index of insulin resistance HOMA-IR. A prognostic index is calculated by formula: K = -24.9 + 0.81 × BMI + 1.06 × T+ 0.02 × T+ 0.6 × T-1.07 × HOMA-IR, where K is the prognostic index； BMI - body weight index, units； T- thickness of epicardial adipose tissue, mm； T- thickness of intraabdominal adipose tissue, mm； T- thickness of posterior wall of left ventricle of heart, mm； HOMA-IR - insulin resistance index, units If K is lower than 9.37 units, a low risk of non-alcoholic fatty liver disease is predicted. If K is within 9.37 ≤ K ≤ 15.38 units predict an average risk of developing non-alcoholic fatty liver disease. If K is more than 15.38 units, a high risk of non-alcoholic fatty liver disease is predicted.EFFECT: method provides predicting development of non-alcoholic fatty liver disease by calculating a prognostic index.1 cl
